Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Torsdag 31 Oktober | 13:18:07 Europe / Stockholm

Svenska | English

BioStock

BioStock: The temperature of Cereno Scientific after major news

2024-10-22 08:29:57

Cereno Scientific has recently announced the selection of a rare disease, idiopathic pulmonary fibrosis, as the target indication for its second drug candidate, CS014. Along with the new data for its lead candidate, CS1, this marks a clear shift in strategy and focus: rare diseases that today leave patients without effective treatment options. CEO Sten R. Sörensen visited BioStocks studio to talk more about this.

Watch the interview with CEO Sten R. Sörensen at biostock.se:
https://www.biostock.se/en/2024/10/the-temperature-of-cereno-scientific-after-major-news/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

BioStock

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden